+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Encephalitis Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Encephalitis Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Sepsis- Pipeline Insight, 2025 - Product Thumbnail Image

Sepsis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Subcutaneous Immunoglobulin Market - Global Forecast 2025-2030 - Product Thumbnail Image

Subcutaneous Immunoglobulin Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
From
From
Intravenous Immunoglobulin Market Report 2025 - Product Thumbnail Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Immunoglobulins Market Report 2025 - Product Thumbnail Image

Immunoglobulins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Guillain-Barre Syndrome Market - Global Forecast 2025-2030 - Product Thumbnail Image

Guillain-Barre Syndrome Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
From
From
Loading Indicator